Dott set for UK debut following Government approval

Dott is among the first micromobility companies to be approved for UK e-scooter trials after ‘exceeding’ the necessary requirements set out by the Government.

The brand’s scooters have been assessed and accepted by the DfT’s Vehicle Classification Agency, which requires a minimum of two brakes, large wheels and good lighting. Dott’s e-scooters come armed with large 10in wheels, a triple braking system and an extra-wide standing board, alongside swappable, long-life battery technology.

Once given final approval by Secretary of State for Transport Grant Shapps, Dott will be ready to roll out in the UK.

“Receiving the green light for our scooters from the DfT is a massive milestone and is a key step to enabling our UK launches, said Duncan Robertson, head of UK development for Dott. “The DfT has set a high bar for scooter quality and it is testament to our focus on hardware that our approval has been granted so quickly.

“Having robust, safe and reliable scooters is absolutely essential for providing a premium service to UK cities. We look forward to launching and bringing our fleets to UK streets very soon. ”

Henri Moissinac, Dott CEO and co-founder, added: “As lockdowns ease across Europe, individual, emission-free, socially distanced transport is vital to prevent spikes of pollution and car usage. Research suggests around 60% of all car journeys in the UK are for distances of 1km-5km, so the green impact of e-scooters in Britain cannot be understated.

“At Dott, we are delighted to play a part in building a flexible, multi-modal transport system that brings citizens more affordable and sustainable mobility choices. For the UK, this is only the beginning; we can’t wait to see what comes next.”

Dott currently operates over 20,000 e-scooters in 13 cities in Belgium, France, Germany, Italy and Poland.

In other news…

TfL looking for e-scooter operators for year-long rental trial in capital

TfL, London Councils and London’s boroughs are working together on plans for a trial of …